Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.68 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | APAF1 | O14727 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31307958 | 1.00 | CYP1A2 (0.68) | CYP1A2CYP2A6ALDH1A1RXFP1TSHR | |
| SCHEMBL3743600 | 0.93 | CYP1A2 (0.59) | CYP1A2CYP2A6ALDH1A1RXFP1TSHR | |
| Acetic Acid SCHEMBL2649892 | 0.87 | RXFP1 (0.53) | CYP1A2CYP2A6ALDH1A1RXFP1PKM | |
| SCHEMBL30547318 | 0.84 | CYP1A2 (0.68) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL7836756 | 0.84 | CYP1A2 (0.68) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL29363045 | 0.83 | CYP1A2 (1.00) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL29429114 | 0.83 | RXFP1 (0.48) | CYP1A2CYP2A6ALDH1A1RXFP1TSHR | |
| SCHEMBL30710586 | 0.83 | RXFP1 (0.48) | CYP1A2CYP2A6ALDH1A1RXFP1TSHR | |
| SCHEMBL29447796 | 0.83 | CYP1A2 (1.00) | CYP1A2CYP2A6ALDH1A1TSHRACHE | |
| SCHEMBL161370 | 0.83 | CYP1A2 (1.00) | CYP1A2CYP2A6ALDH1A1TSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528685-A | Preparation method of 1-bromo-4-methylnaphthalene | 利尔化学股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118344277-A | Pyrrole derivative and preparation method and application thereof | 山东大学 | 2024-07-16 | — | — | CN | claimed |
| CN-117658981-A | Isatin derivative, pharmaceutically acceptable salt, pharmaceutical composition and application | 武汉大学人民医院（湖北省人民医院） | 2024-03-08 | — | — | CN | claimed |
| CN-114874232-B | Preparation method and application of thienopyrimidinone compound containing ethyl naphthalene structure | 山东大学 | 2023-11-14 | — | — | CN | claimed |
| CN-116874406-A | Indolyl sulfonamide compound and preparation method and application thereof | 山东大学 | 2023-10-13 | — | — | CN | claimed |
| CN-114907344-B | Beta-carboline-1-propionic acid and indole derivatives, and preparation method and application thereof | 山东大学 | 2023-06-30 | — | — | CN | claimed |
| CN-115504848-A | Method for preparing 1,4-dimethylnaphthalene | 利尔化学股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-114907344-A | Beta-carboline-1-propionic acid and indole derivatives, and preparation method and application thereof | 山东大学 | 2022-08-16 | — | — | CN | claimed |
| CN-114874232-A | Preparation method and application of thienopyrimidinone compound containing ethyl naphthalene structure | 山东大学 | 2022-08-09 | — | — | CN | claimed |
| US-20130184484-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | UNIVERSITE DE NICE SOPHIA ANTIPOLIS (FR) | 2013-07-18 | — | — | US | claimed |
| US-20110282090-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | UNIVERSITE DE NICE SOPHIA ANTIPOLIS (FR) | 2011-11-17 | — | — | US | claimed |
| EP-0087269-B1 | PLANT GROWTH REGULATORS | COALITE GROUP PLC (GB) | 1986-11-20 | — | — | EP | claimed |
| EP-0087269-A1 | Plant growth regulators | COALITE GROUP PLC (GB) | 1983-08-31 | — | — | EP | claimed |
| US-20250289812-A1 | COMPOUND FOR TREATING THROMBOTIC DISEASES | RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2025-09-18 | — | — | US | disclosed |
| US-20250243171-A1 | QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE | ARTHROSI THERAPEUTICS, INC. | 2025-07-31 | — | — | US | disclosed |
| CN-119528684-A | Preparation method of 1-chloro-4-methylnaphthalene | 利尔化学股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-0087269-A1 | Plant growth regulators | COALITE GROUP PLC (GB) | 1983-08-31 | — | — | EP | disclosed |
| US-4276305-A | INSECTICIDES, MITICIDES | HOFFMANN-LA ROCHE INC. (US) | 1981-06-30 | — | — | US | disclosed |
| EP-0017915-A1 | Use of phototropic organic compounds to control the transmission of electromagnetic radiation, and phototropic compounds | BASF Aktiengesellschaft (DE) | 1980-10-29 | — | — | EP | disclosed |
| US-3989746-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | IKEDA MOHANDO CO., LTD. (JA) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289812-A1 | COMPOUND FOR TREATING THROMBOTIC DISEASES | ITGB3, SRC, FYN | CYP1A2 3907/4885CYP2A6 3393/4885ALDH1A1 4001/4885 |
| US-20110282090-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | ME1, MEN1, CYP2B6 | CYP1A2 323/4885CYP2A6 8/4885ALDH1A1 3043/4885 |
| US-20250243171-A1 | QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE | EGFR, ABL1, ERBB2 | CYP1A2 2228/4885CYP2A6 2802/4885ALDH1A1 2795/4885 |
| US-20130184484-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | ME1, MEN1, CYP2B6 | CYP1A2 323/4885CYP2A6 8/4885ALDH1A1 3043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.